Enact Holdings, Inc. operates as a private mortgage insurance company in the United States. The company engages in writing and assuming residential mortgage guaranty insurance. It also offers private mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; contract underwriting services for mortgage lenders; and mortgage-related reinsurance products. The company primarily serves originators of residential mortgage loans. The company was formerly known as Genworth Mortgage Holdings, Inc. and changed its name to Enact Holdings, Inc. in May 2021. Enact Holdings, Inc. was founded in 1981 and is headquartered in Raleigh, North Carolina. Enact Holdings, Inc. is a subsidiary of Genworth Holdings Inc.

Enact Holdings Inc.

In a dramatic turn of events, Perrigo Company plc finds itself at the center of a class action lawsuit, with shareholders alleging they were misled...

Perrigo Faces Shareholder Lawsuit Over Nestlé Deal

In a dramatic turn of events, Skye Bioscience, Inc. finds itself at the center of a class action lawsuit, accused of misleading investors about the...

Skye Bioscience Faces Lawsuit Over Misleading Claims

Active Biotech AB ( ($SE:ACTI) ) has shared an update. Active Biotech AB has announced a rights issue of shares amounting to approximately SEK 70 m...

Active Biotech Announces SEK 70 Million Rights Issue

Aduro Clean Technologies ( ($TSE:ACT) ) has shared an announcement. Aduro Clean Technologies announced the successful pilot-scale steam-cracking of...

Aduro Achieves Milestone in Plastic Recycling with Successful Steam-Cracking Trials

Primo Water Corporation is currently embroiled in a class action lawsuit that could have significant implications for its shareholders. The lawsuit...

Primo Water’s Merger Woes Spark Investor Lawsuit

Firefly Aerospace is under fire as a class action lawsuit has been launched against the company, accusing it of misleading investors with inflated ...

Firefly Aerospace Faces Legal Turbulence Over Misleading Claims

Craig-Hallum analyst Albert Lowe maintained a Buy rating on Actuate Therapeutics, Inc. today and set a price target of $25.00. Lowe covers the Heal...

Craig-Hallum Reaffirms Their Buy Rating on Actuate Therapeutics, Inc. (ACTU)

Proact IT Group AB ( ($SE:PACT) ) just unveiled an update. Proact IT Group AB announced the resignation of CFO Noora Jayasekara, who will remain in...

Proact IT Group AB Announces CFO Resignation

In a dramatic turn of events, Inspire Medical Systems, Inc. finds itself at the center of a class action lawsuit, as shareholders allege the compan...

Inspire Medical Faces Legal Heat Over Product Launch

In a report released yesterday, Jeff Martin from Roth MKM maintained a Buy rating on Transact Technologies, with a price target of $5.00. According...

Roth MKM Keeps Their Buy Rating on Transact Technologies (TACT)

Transact Technologies ( ($TACT) ) has provided an announcement. On November 3, 2025, TransAct Technologies signed a Third Amendment to Lease with O...

Transact Technologies Extends Lease with Reduced Space

In a dramatic turn of events, Synopsys, Inc. finds itself at the center of a class action lawsuit, as shareholders allege that the company engaged ...

Synopsys Faces Class Action Over AI Misstatements

CarMax, Inc., a major player in the automotive retail industry, is currently facing a class action lawsuit that could have significant implications...

CarMax Faces Legal Heat Over Misleading Growth Claims

Craig-Hallum analyst Anthony Stoss reiterated a Buy rating on Acacia Research today and set a price target of $5.00. Stoss covers the Technology se...

Craig-Hallum Sticks to Its Buy Rating for Acacia Research (ACTG)

Acacia Research Corp. (($ACTG)) has held its Q3 earnings call. Read on for the main highlights of the call. Acacia Research Corp. recently held its...

Acacia Research Corp. Reports Strong Revenue Growth

James Hardie Industries plc is facing a significant class action lawsuit, as allegations surface that the company misled investors about the true s...

James Hardie Faces Lawsuit Over Misleading Demand Claims

In a dramatic turn of events, Marex Group plc finds itself at the center of a class action lawsuit that could have far-reaching implications for it...

Market Cap	$5.34B	P/E Ratio	8.67
52W High	$39.47	52W Low	$30.79
Div Yield	84.0%	Payout Ratio	69.1%
EPS Growth 3Y	N/A	52W Position	88.7%
Overall Score	81	Value Score	100
Quality Score	--	Technical Score	63

EPS Current Est	$4.44	EPS Next Est	$4.6
EPS Growth Est	+3.6%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ACT	$38.49	+1.45%	262.61K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ACT	$38.49	+1.4%	262.61K
3
4
5
6

ACT

ACT

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Enact Holdings Inc. Data in Excel

Get Enact Holdings Inc. Data in Excel